Literature DB >> 16762922

Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling.

Ning Wang1, Zhe Li, Ronghua Ding, Gerald D Frank, Takaaki Senbonmatsu, Erwin J Landon, Tadashi Inagami, Zhizhuang Joe Zhao.   

Abstract

SHP-1 and SHP-2 are two Src homology 2 domain-containing tyrosine phosphatases with major pathological implications in cell growth regulating signaling. They share significant overall sequence identity, but their biological functions are often opposite. SHP-1 is generally considered as a negative signal transducer and SHP-2 as a positive one. However, the precise role of each enzyme in shared signaling pathways is not well defined. In this study, we investigated the interaction of these two enzymes in a single cell system by knocking down their expressions with small interfering RNAs and analyzing the effects on epidermal growth factor signaling. Interestingly, knockdown of either SHP-1 or SHP-2 caused significant reduction in the activation of ERK1/2 but not Akt. Furthermore, SHP-1, SHP-2, and Gab1 formed a signaling complex, and SHP-1 and SHP-2 interact with each other. The interaction of SHP-1 with Gab1 is mediated by SHP-2 because it was abrogated by knockdown of SHP-2, and SHP-2, but not SHP-1, binds directly to tyrosine-phosphorylated Gab1. Together, the data revealed that both SHP-1 and SHP-2 have a positive role in epidermal growth factor-induced ERK1/2 activation and that they act cooperatively rather than antagonistically. The interaction of SHP-1 and SHP-2 may be responsible for previously unexpected novel regulatory mechanism of cell signaling by tyrosine phosphatases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762922      PMCID: PMC2377019          DOI: 10.1074/jbc.M605018200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Syuichi Muto; Toshiro Sugiyama; Takeshi Azuma; Masahiro Asaka; Masanori Hatakeyama
Journal:  Science       Date:  2001-12-13       Impact factor: 47.728

Review 2.  The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors.

Authors:  Keigo Nishida; Toshio Hirano
Journal:  Cancer Sci       Date:  2003-12       Impact factor: 6.716

Review 3.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.

Authors:  Benjamin G Neel; Haihua Gu; Lily Pao
Journal:  Trends Biochem Sci       Date:  2003-06       Impact factor: 13.807

4.  Blocking the function of tyrosine phosphatase SHP-2 by targeting its Src homology 2 domains.

Authors:  Runxiang Zhao; Xueqi Fu; Lirong Teng; Qingshan Li; Zhizhuang Joe Zhao
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

5.  Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Marco Tartaglia; Charlotte M Niemeyer; Alessandra Fragale; Xiaoling Song; Jochen Buechner; Andreas Jung; Karel Hählen; Henrik Hasle; Jonathan D Licht; Bruce D Gelb
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

6.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

7.  Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function.

Authors:  Daohong Chen; Hideki Iijima; Takashi Nagaishi; Atsushi Nakajima; Sara Russell; Raktima Raychowdhury; Victor Morales; Christopher E Rudd; Nalan Utku; Richard S Blumberg
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 8.  The function of the protein tyrosine phosphatase SHP-1 in cancer.

Authors:  Chengyu Wu; Mingzhong Sun; Lijun Liu; G Wayne Zhou
Journal:  Gene       Date:  2003-03-13       Impact factor: 3.688

9.  Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis.

Authors:  Mignon L Loh; Shashaank Vattikuti; Suzanne Schubbert; Melissa G Reynolds; Elaine Carlson; Kenneth H Lieuw; Jennifer W Cheng; Connie M Lee; David Stokoe; Jeannette M Bonifas; Nicole P Curtiss; Jason Gotlib; Soheil Meshinchi; Michelle M Le Beau; Peter D Emanuel; Kevin M Shannon
Journal:  Blood       Date:  2003-11-26       Impact factor: 22.113

10.  Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.

Authors:  Marco Tartaglia; Simone Martinelli; Giovanni Cazzaniga; Viviana Cordeddu; Ivano Iavarone; Monica Spinelli; Chiara Palmi; Claudio Carta; Andrea Pession; Maurizio Aricò; Giuseppe Masera; Giuseppe Basso; Mariella Sorcini; Bruce D Gelb; Andrea Biondi
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

View more
  15 in total

1.  Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.

Authors:  Ngozi Monu; Alan B Frey
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

Review 2.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

3.  Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts.

Authors:  Hema Rangaswami; Raphaela Schwappacher; Nisha Marathe; Shunhui Zhuang; Darren E Casteel; Bodo Haas; Yong Chen; Alexander Pfeifer; Hisashi Kato; Sanford Shattil; Gerry R Boss; Renate B Pilz
Journal:  Sci Signal       Date:  2010-12-21       Impact factor: 8.192

4.  Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential.

Authors:  Timothy J Patterson; Robert H Rice
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-14       Impact factor: 4.219

5.  Reactive oxygen species and epidermal growth factor are antagonistic cues controlling SHP-2 dimerization.

Authors:  Aurelio Pio Nardozza; Melania D'Orazio; Riccardo Trapannone; Salvatore Corallino; Giuseppe Filomeni; Marco Tartaglia; Andrea Battistoni; Gianni Cesareni; Luisa Castagnoli
Journal:  Mol Cell Biol       Date:  2012-03-12       Impact factor: 4.272

6.  Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.

Authors:  Kristopher C Carver; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

7.  Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.

Authors:  Mary B Dail; L Allen Shack; Janice E Chambers; Shane C Burgess
Journal:  Toxicol Sci       Date:  2008-09-16       Impact factor: 4.849

8.  PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.

Authors:  Linda Sooman; Simon Ekman; Georgios Tsakonas; Archita Jaiswal; Sanjay Navani; Per-Henrik Edqvist; Fredrik Pontén; Stefan Bergström; Mikael Johansson; Xuping Wu; Erik Blomquist; Michael Bergqvist; Joachim Gullbo; Johan Lennartsson
Journal:  Tumour Biol       Date:  2014-02-09

9.  SHP-2 expression negatively regulates NK cell function.

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo.

Authors:  Ingunn M Stromnes; Carla Fowler; Chanel C Casamina; Christina M Georgopolos; Megan S McAfee; Thomas M Schmitt; Xiaoxia Tan; Tae-Don Kim; Inpyo Choi; Joseph N Blattman; Philip D Greenberg
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.